Alveolar and Bone Marrow–derived Macrophages Differ in Metabolism and Glutamine Utilization
American Journal of Respiratory Cell and Molecular Biology · 2025
DOI: 10.1165/rcmb.2023-0249oc ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Respiratory Cell and Molecular Biology, 2025. Verfasst von Christine L Vigeland und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine. Hauptthemen laut MEDLINE: Glutamine, Macrophages, Alveolar, Macrophages, Bone Marrow Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Science Foundation, NIDDK NIH HHS.
Abstract (Originalsprache)
Changes in metabolic activity are key regulators of macrophage activity. Proinflammatory macrophages upregulate glycolysis, which promotes an inflammatory phenotype, whereas prorepair macrophages rely on oxidative metabolism and glutaminolysis to support their activity. Work to understand how metabolism regulates macrophage phenotype has been done primarily in macrophage cell lines and bone marrow–derived macrophages (BMDM). Our study sought to understand changes in metabolic activity of murine tissue-resident alveolar macrophages (AM) in response to LPS stimulation and to contrast them to BMDM. These studies also determined the contribution of glutamine metabolism using the glutamine inhibitor, 6-diazo-5-oxo-L-norleucine (DON). We found that compared with BMDM, AM have higher rates of oxygen consumption and contain a higher concentration of intracellular metabolites involved in fatty acid oxidation. In response to LPS, BMDM, but not AM, increased rates of glycolysis. Inhibition of glutamine metabolism using DON altered the metabolic activity of AM but not BMDM. Within AM, glutamine inhibition led to increases in intracellular metabolites involved in glycolysis, the tricarboxylic acid (TCA) cycle, fatty acid oxidation, and amino acid metabolism. Glutamine inhibition also altered the metabolic response to LPS within AM but not BMDM. Our data reveal striking differences in the metabolic activity of AM and BMDM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine.
- Marsico Lung Institute.
- Division of Endocrinology, Department of Pediatrics, University of North Carolina School of Medicine, and.
- Department of Chemistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
ORCID-Profile: Christine L Vigeland, Claire M Doerschuk
Förderung
- NHLBI NIH HHS
- National Science Foundation
- NIDDK NIH HHS
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Vigeland, C. L., Link, J. D., Beggs, H. S., Alwarawrah, Y., Ehrmann, B. M., Dang, H., & Doerschuk, C. M. (2025). Alveolar and Bone Marrow–derived Macrophages Differ in Metabolism and Glutamine Utilization. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2023-0249oc
Vancouver
Vigeland CL, Link JD, Beggs HS, Alwarawrah Y, Ehrmann BM, Dang H, et al. Alveolar and Bone Marrow–derived Macrophages Differ in Metabolism and Glutamine Utilization. American Journal of Respiratory Cell and Molecular Biology. 2025. doi:10.1165/rcmb.2023-0249oc
BibTeX
@article{Vigeland2025,
author = {Vigeland, Christine L and Link, Jordan D and Beggs, Henry S and Alwarawrah, Yazan and Ehrmann, Brandie M and Dang, Hong and Doerschuk, Claire M},
title = {Alveolar and Bone Marrow–derived Macrophages Differ in Metabolism and Glutamine Utilization},
journal = {American Journal of Respiratory Cell and Molecular Biology},
year = {2025},
doi = {10.1165/rcmb.2023-0249oc}
}
EUVIMED